Long-term weight loss with GLP-1 medications
This is a news story, published by ScienceDaily, that relates primarily to Cleveland Clinic news.
drug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsScienceDaily news
For more news from ScienceDaily, you can click here:
more news from ScienceDailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
obesity treatment. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest semaglutide news, significant weight loss news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
sustained weight lossScienceDaily
•Key factors that impact long-term weight loss in patients prescribed GLP-1 RA medications
81% Informative
Cleveland Clinic study identified key factors that can impact long-term weight loss of patients with obesity who were prescribed GLP-1 RA medications.
Study focuses on FDA -approved injectable injectable semaglutide and liraglamutide for the treatment of type 2 diabetes or obesity.
The study was published in JAMA Network Open ..
37.4% of patients receiving semaglutide for obesity achieved 10% or more body weight reduction compared to 16.6% for type 2 diabetes.
14.5% of those receiving liraglutanide for.
obesity achieved.
10% weight reduction one year after the initial prescriptions.
Patients who persisted with the medication within the first year or had between 90-275 days of medication coverage.
VR Score
92
Informative language
97
Neutral language
78
Article tone
formal
Language
English
Language complexity
61
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links